Alfei, Barbara
 Distribuzione geografica
Continente #
EU - Europa 126
NA - Nord America 95
AS - Asia 67
SA - Sud America 10
AF - Africa 1
Totale 299
Nazione #
US - Stati Uniti d'America 93
DE - Germania 76
CN - Cina 29
SG - Singapore 24
UA - Ucraina 16
SE - Svezia 12
BR - Brasile 9
TR - Turchia 8
FR - Francia 6
IT - Italia 4
FI - Finlandia 3
GB - Regno Unito 3
ID - Indonesia 3
IE - Irlanda 3
RU - Federazione Russa 2
VN - Vietnam 2
AR - Argentina 1
JP - Giappone 1
MX - Messico 1
NL - Olanda 1
PA - Panama 1
SC - Seychelles 1
Totale 299
Città #
Chandler 17
San Mateo 10
Singapore 10
Beijing 9
Izmir 8
Jacksonville 7
Nanjing 7
Nürnberg 7
Ashburn 6
Brooklyn 4
Los Angeles 4
Nanchang 4
Boston 3
Dublin 3
Jakarta 3
Princeton 3
Renton 3
Seattle 3
Indiana 2
Jiaxing 2
Kunming 2
Marseille 2
Milan 2
Springfield 2
Wilmington 2
Amsterdam 1
Apiaí 1
Buenos Aires 1
Chicago 1
Columbus 1
Dallas 1
Erechim 1
Fairfield 1
Fremont 1
Hangzhou 1
Houston 1
Jinan 1
Monte Alto 1
Montes Claros 1
Moscow 1
Norwalk 1
Pinheiro 1
Piquerobi 1
Piracicaba 1
Porangatu 1
Porto Alegre 1
San Jose 1
Shanghai 1
Stockholm 1
Tepatitlán de Morelos 1
Thanh Hóa 1
Turin 1
University Park 1
Valdosta 1
Vinh 1
Waltham Forest 1
Zhengzhou 1
Totale 157
Nome #
Prognostic factors for survival in patients with early-intermediate hepatocellular carcinoma undergoing non-surgical therapy: comparison of Okuda, CLIP, and BCLC staging systems in a single Italian centre. 110
Liver metastases of endocrine tumour associated with multiple endocrine neoplasia type 1: a sustained response to interferon therapy or a peculiar benign course? 104
NON ALCOHOLIC STEATOHEPATITIS (NASH) INDUCED BY CARBAMAZEPINE AND VARIEGATE PORPHYRIA 86
Totale 300
Categoria #
all - tutte 1.171
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.171


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202124 2 3 0 4 3 0 3 0 3 0 6 0
2021/202228 2 5 0 4 0 2 1 7 1 0 3 3
2022/202346 5 4 4 4 5 5 4 4 8 0 1 2
2023/202417 1 10 0 0 0 0 3 0 0 1 1 1
2024/202542 3 0 3 0 5 1 1 2 13 5 4 5
2025/202614 14 0 0 0 0 0 0 0 0 0 0 0
Totale 300